FierceBiotech Apr 21, 2026 Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure
FierceBiotech Apr 21, 2026 With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
Lonza News Apr 21, 2026 Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
Lonza News Apr 21, 2026 FDA-backed drug project tests modeling to reduce some human studies - Stock Titan
Thermo Fisher Apr 21, 2026 Saladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays - Clinical Lab Products
Thermo Fisher Apr 21, 2026 TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance
Agilent Apr 21, 2026 Mirae Asset Global Investments Co. Ltd. Grows Holdings in Agilent Technologies, Inc. $A - MarketBeat
Insilico Medicine Apr 21, 2026 Insilico Medicine Showcases Preclinical Breakthroughs for Four AI-Powered Oncology Pipelines at AACR Annual Meeting 2026 - Insilico Medicine
Lonza News Apr 21, 2026 Lonza Group AG stock (CH0013841017): Is its biopharma contract model resilient enough for new growth - AD HOC NEWS
FierceBiotech Apr 21, 2026 Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection